Results
1 -
10 of
81Yolanda Schaerli and Florian Hollfelder.
The potential of microfluidic water-in-oil droplets in experimental biology, Mol. Biosyst., 2009, 5, 1392. Jingjie Cui, Yakun Ge, Shaowei Chen, Hongshi Zhao, Hong Liu, Zhen Huang, Huaidong Jiang and Jing Chen.
Nano-p–n junction heterostructure TiO nanobelts for the electrochemical detection of anticancer drug and biointeractions with cancer cells, J. Mater. Chem. B, 2013, 1, 2072. Duclos Franck, Abell Lynn M., Harden David G., Pike Kristen, Nowak Kimberly, Locke Gregory A., Duke Gerald J., Liu Xiaoqin, Fernando Gayani, Shaw Scott A., Vokits Benjamin P., Wurtz Nicholas R., Viet Andrew, Valente Meriah N., Stachura Sylwia, Sleph Paul, Khan Javed A., Gao Ji, Dongre Ashok R., Zhao Lei, Wexler Ruth R., Gordon David A., Kick Ellen K..
Triazolopyrimidines identified as reversible myeloperoxidase inhibitors, MedChemComm, 2017 Wnt/??-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance, Nature Communications Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents, Cancer Chemotherapy and Pharmacology Toxicity of intracranial and intraperitoneal O6-benzyl guanine in combination with BCNU delivered locally in a mouse model, Cancer Chemotherapy and Pharmacology Acquired resistance to Ou200a6-benzylguanine plus chloroethylnitrosoureas in human breast cancer, Cancer Chemotherapy and Pharmacology Effect of Pentoxifylline, ethacrynic acid and O6-benzyl-guanine as resistance modifiers to alkylating agents in haematological malignancies, Cancer Treatment An Update Nanoformulations for Therapeutics, Advances in Personalized Nanotherapeutics Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide, Medical Molecular Morphology